Sunovion, Novartis ink licensing deal for inhaled COPD drugs

Novartis (NYSE:NVS) said today that it out-licensed its U.S. commercial rights for 3 inhaled chronic obstructive pulmonary disease drugs to Sunovion Pharmaceuticals. Novartis will commercialize the Utibron Neohaler, Seebri Neohaler, and Arcapta Neohaler inhalation powders outside of the U.S.

The Switzerland-based company will manufacture the powders for Sunovion, according to the agreement.

Venture Valuation’s Biotechgate and California Life Sciences Association (CLSA) have announced that they are collaborating to help create an in-depth member directory for CLSA and a company directory for California. The CSLA member directory will be available through the association’s website and will be a part of the Biotechgate global life sciences database that already […]

For over 25 years Foster Corporation has been serving medical device manufacturers with technology and service in custom biomedical polymer compounding. Within two ISO 13485:2003 and ISO 9001:2008 certified facilities, Foster offers expert formulation development and production of polymer enhancements including radiopaque fillers, custom colors and other specialty additives. Featured technology: ProPell Compounds, PureEase, Medibatch Color Concentrates […]

The wearable lab at Flex (formerly Flextronics) reports it’s making strides when it comes to creating devices that are transparent and seamless. “Usually when you think about healthcare, you picture a person in a bed with wires running all around. We think healthcare should be as easy as putting on a T-shirt,” said John Carlson, president […]

Boston MedTech Advisors supports its clients (from start-ups to Fortune 500 companies) in the commercialization of new products and services by addressing the highly inter-dependent regulatory, clinical studies, reimbursement, marketing and business development challenges of the global medical technology industry. Featured services: Case studies Boston MedTech Advisors has been working on addressing spine problems for several […]

The U.S. FDA has been seeking to prevent shortages of medical devices and other products after disruptions caused by Hurricanes Harvey, Irma and Maria. “These storms have hit hard in areas where there are a significant number of farmers, food distributors, and medical product manufacturers, including Houston, Florida, and now Puerto Rico and the U.S. […]

Edwards Lifesciences is planning some important TAVR reveals during the PCR London Valves 2017 course that is underway. The Irvine, Calif.–based cardio devices company said yesterday that it plans to introduce the new Sapien 3 Ultra valve during the event, which runs until tomorrow. Edwards officials expect the Sapien 3 Ultra to receive CE Mark […]

Theraclion (Malakoff, France) today announced wins when it comes to use of its echotherapy treatment in Germany and Hong Kong. The Heilfürsorge Bundespolizei (medical insurance of the federal German police force) now covers echotherapy for both breast fibroadenomas and thyroid nodules. “It is a strong mark of recognition for our technology that the German federal police […]

Cognition Corp., headquartered in Lexington, Mass., has been offering solutions for medical device, pharmaceutical, and combination products compliance and commercialization for more than 10 years. The Cockpit Platform provides the framework for an extensive set of compliance templates. These templates, which include Risk Management and Design Controls, along with professional services, give companies a jump-start […]

A research team from Columbia Engineering’s Creative Machines lab developed a synthetic soft muscle that has a strain density 15 times larger than natural muscle and can lift 1,000 times its own weight that could propel soft robotics creation forward. According to the study “Soft Material for Soft Actuators” published in Nature Communications, the material… […]

The medical device industry is growing at a healthy and steady pace, according to new reports that EY and Evaluate released today during AdvaMed’s annual Medtech Conference. “The results of this year’s report is a direct contrast to last year and tells a positive story about the future of the medtech industry,” said EY partner […]

Abbott (NYSE: ABT) has won FDA approval of MR-compatible ICDs – an indication that it could be making good executing on key priorities it inherited when it acquired St. Jude Medical for $25 billion early this year. The news today “lends incremental credibility to our thesis that ABT can and will have a positive impact on STJ […]